Cocktail-Dosing Microdialysis Study to Simultaneously Assess Delivery of Multiple Organic-Cationic Drugs to the Brain
Overview
Pharmacy
Affiliations
Brain microdialysis is a powerful tool to estimate brain-to-plasma unbound concentration ratio at the steady state (Kp,uu) of compounds by direct measurement of the unbound concentration in brain interstitial fluid. Here, we evaluated a method to estimate Kp,uu values of multiple organic-cationic drugs simultaneously, by means of brain microdialysis combined with cocktail dosing. Five cationic drugs (diphenhydramine, memantine, oxycodone, pyrilamine, and tramadol), substrates of the proton-coupled organic cation antiport system, were selected as model drugs, and compared under single-dosing and cocktail-dosing conditions. We selected doses of the drugs at which no significant drug-drug interaction occurs at the proton-coupled organic cation antiport system in the blood-brain barrier (BBB). This was confirmed by uptake studies in hCMEC/D3 cells, an in vitro BBB model. The Kp,uu values after cocktail administration were in the range of 1.8-5.2, and were in good agreement with those after single administration. These results suggest that the microdialysis method with cocktail dosing is suitable to estimate Kp,uu values of several cationic drugs simultaneously, if there is no drug-drug interaction during BBB transport. The method could be useful for evaluating drug candidates with high Kp,uu values at an early stage in the development of central nervous system-acting drugs.
Region-independent active CNS net uptake of marketed H/OC antiporter system substrates.
Ballgren F, Hu Y, Li S, van de Beek L, Hammarlund-Udenaes M, Loryan I Front Cell Neurosci. 2024; 18:1493644.
PMID: 39534684 PMC: 11554538. DOI: 10.3389/fncel.2024.1493644.
Svane N, Pedersen A, Rodenberg A, Ozgur B, Saaby L, Bundgaard C Fluids Barriers CNS. 2024; 21(1):39.
PMID: 38711118 PMC: 11071266. DOI: 10.1186/s12987-024-00544-6.
Ballgren F, Hammarlund-Udenaes M, Loryan I Pharm Res. 2023; 40(11):2715-2730.
PMID: 37610619 PMC: 10733202. DOI: 10.1007/s11095-023-03583-0.
Gerson J, Erdal M, McDonough M, Ploense K, Dauphin-Ducharme P, Honeywell K Sci Adv. 2023; 9(20):eadg3254.
PMID: 37196087 PMC: 10191434. DOI: 10.1126/sciadv.adg3254.
Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats.
Stanton J, Williams E, Betterton R, Davis T, Ronaldson P Exp Neurol. 2022; 357:114181.
PMID: 35905840 PMC: 9620710. DOI: 10.1016/j.expneurol.2022.114181.